Protembis
Aachen, DE · Founded 2013 · 16 employees on LinkedIn · 3 known investors
Protembis is a German medical device company developing the ProtEmbo Cerebral Protection System, an intra-aortic filter device inserted via the left radial artery that shields the brain from embolic debris during transcatheter aortic valve replacement (TAVR) and other left-sided heart procedures. The device aims to reduce the risk of stroke and cognitive decline for cardiac patients and is undergoing clinical investigation.
Founders & leadership
KV
Karl von MangoldtCo-Chief Executive Officer
CR
Conrad RasmusCo-Chief Executive Officer
OM
Oliver MarseilleCTO
Investors · 3
Frequently asked questions
- What does Protembis do?
- Protembis is a German medical device company developing the ProtEmbo Cerebral Protection System, an intra-aortic filter device inserted via the left radial artery that shields the brain from embolic debris during transcatheter aortic valve replacement (TAVR) and other left-sided heart procedures. The device aims to reduce the risk of stroke and cognitive decline for cardiac patients and is undergoing clinical investigation.
- Who are Protembis's investors?
- Protembis's investors include European Investment Bank, TechVision Fonds, XGEN Venture.
- Where is Protembis headquartered?
- Protembis is headquartered in Aachen, DE.